A Pilot Trial to Test the Feasibility of Utilizing Home Blood Pressure Monitoring to Optimize the Administration of Midodrine Among Decompensated Cirrhosis Patients
- Conditions
- Portal HypertensionAscites HepaticCirrhosis, Liver
- Registration Number
- NCT05928624
- Lead Sponsor
- University of California, San Francisco
- Brief Summary
This is a randomized single-blind feasibility trial to test the utilization of home blood pressure devices to improve the clinical management of decompensated cirrhosis patients.
- Detailed Description
This is a feasibility trial to determine the feasibility of using home monitoring devices (e.g. blood pressure cuffs) to improve outcomes for cirrhosis patients.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 69
- Patients will need to have decompensated cirrhosis defined as a Child Pugh Score ≥ 7
- None
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change in Mean Arterial Pressure Baseline and 24 Weeks The investigators will compare the change in mean arterial pressure before and after utilization of the data generated from the home monitoring.
- Secondary Outcome Measures
Name Time Method Change in Ascites Burden Baseline and 24 Weeks The investigators will compare the change in ascites burden, defined as the total volume of ascites removed during the study period, before and after utilization of the data generated from the home monitoring.
Trial Locations
- Locations (1)
University of California San Francisco
🇺🇸San Francisco, California, United States
University of California San Francisco🇺🇸San Francisco, California, United States